Patient treatment preferences for relapsed or refractory multiple myeloma: a plain language summary

This Plain Language Summary of Publication article (PLSP) from Future Oncology examined what treatment characteristics matter most to patients with multiple myeloma, a blood cancer. Researchers looked at patient preferences regarding treatment effectiveness, administration methods, and potential side effects.
Visit the site using this link to read the article.
This PLSP is based on an article called ‘Patient preferences for triple-class–exposed relapsed or refractory multiple myeloma treatment: a discrete-choice study’ and was published in Future Oncology.
Visit T&F Online using the link to read the original article.